{"brief_title": "An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)", "brief_summary": "The purpose of this study is to determine the effect of an approved medication for adults for an investigational use in pediatric patients 3 months to 17 years for the treatment of complicated intra-abdominal infections or acute pelvic infections.", "detailed_description": "The duration of treatment is 18 months.", "condition": ["Infections", "Pelvic Infections"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0826, ertapenem sodium", "Comparator: Ticarcillin/Clavulanate"], "criteria": "Inclusion Criteria: - Patients aged 3 months to 17 years with intra-abdominal infection or acute pelvic infection Exclusion Criteria: - Immune problems - Kidney problems", "gender": "All", "minimum_age": "3 Months", "maximum_age": "17 Years", "healthy_volunteers": "No", "keyword": "Acute pelvic infections", "mesh_term": ["Infection", "Communicable Diseases", "Intraabdominal Infections", "Pelvic Infection", "Pelvic Inflammatory Disease", "Clavulanic Acid", "Clavulanic Acids", "Ertapenem", "Ticarcillin"], "id": "NCT00092170"}